Acetyl-L-Carnitine için Age-Related Cognitive Decline

Mixed results in healthy adults but more consistently positive outcomes in elderly populations with existing cognitive concerns. Used as a prescription drug in some European countries for cognitive impairment.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dacetyl\u002Dl\u002Dcarnitine\u0026condition\u003Dcognitive\u002Ddecline'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

Sonuç

Key Study Findings

Randomized Controlled Trial

Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized …

Dose: None vs: None Outcome: Cognitive decline Etki: None None

Popülasyon: Alzheimer's disease patients

Systematic Review

Acetyl-L-Carnitine in Dementia and Other Cognitive Disorders: A Critical Update.

Dose: None vs: None Outcome: None Etki: None None

Popülasyon: None

Review

Chronic pain and adult hippocampal neurogenesis: translational implications from preclinical studies.

Dose: None vs: None Outcome: None Etki: None None

Popülasyon: Chronic pain patients (preclinical review)

Review

Alpha-synuclein, epigenetics, mitochondria, metabolism, calcium traffic, & circadian dysfunction in Parkinson's disease. An integrated strategy …

Dose: None vs: None Outcome: None Etki: None None

Popülasyon: Parkinson's disease patients

Controlled Clinical Trial

Effect of mitochondrial cofactors and antioxidants supplementation on cognition in the aged canine.

Dose: mitochondrial cofactors + antioxidants vs: control diet Outcome: cognitive function in aged dogs Etki: improved learning and memory None

Popülasyon: Aged beagle dogs

Randomized Controlled Trial n=106 Double-blind

A Phase II Randomized Clinical Trial of a Nutritional Formulation for Cognition and Mood in …

Dose: None vs: placebo Outcome: None Etki: None p = 0.0083

Popülasyon: Alzheimer's disease patients

Key Statistics

Çalışmalar

1000

Katılımcılar

↑

Positive

Derece

Referenced Papers

Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial. RCT

Medicine 2024 3 atıf

Acetyl-L-Carnitine in Dementia and Other Cognitive Disorders: A Critical Update. Review

Nutrients 2020 72 atıf

Alpha-synuclein, epigenetics, mitochondria, metabolism, calcium traffic, & circadian dysfunction in Parkinson's disease. An integrated strategy for management. Review

Ageing research reviews 2017 56 atıf

Chronic pain and adult hippocampal neurogenesis: translational implications from preclinical studies. Other

Journal of pain … 2017 49 atıf

Effect of mitochondrial cofactors and antioxidants supplementation on cognition in the aged canine. Other

Neurobiology of aging 2016 19 atıf

A Phase II Randomized Clinical Trial of a Nutritional Formulation for Cognition and Mood in Alzheimer's Disease. RCT

Journal of Alzheimer's … 2015 112 atıf

Pharmacological interventions for cognitive decline in people with Down syndrome. Meta-Analysis

The Cochrane database … 2015 33 atıf

n-3 polyunsaturated fatty acids supplementation enhances hippocampal functionality in aged mice. Other

Frontiers in aging … 2014 111 atıf

A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia. RCT

The journal of … 2010 70 atıf

Dietary supplementation with a combination of alpha-lipoic acid, acetyl-L-carnitine, glycerophosphocoline, docosahexaenoic acid, and phosphatidylserine reduces oxidative damage to murine brain … Other

Nutrition research (New … 2009 65 atıf

Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention. Review

Alternative medicine review … 2008

Acetyl-L-carnitine and alpha-lipoic acid supplementation of aged beagle dogs improves learning in two landmark discrimination tests. Other

FASEB journal : … 2007 52 atıf

Acetyl-L-carnitine for dementia. Systematic Review

The Cochrane database … 2003 94 atıf

A review of nutrients and botanicals in the integrative management of cognitive dysfunction. Review

Alternative medicine review … 1999 112 atıf

[Methodology of a clinical controlled study of L-acetylcarnitine]. CCT

La Clinica terapeutica 1990 3 atıf

Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine--in patients with organic brain syndrome. RCT

International journal of … 1990

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Yaygın Kullanılan Dozajlar

general:: 500-2,000 mg/day
cognitivesupport:: 1,500-3,000 mg/day

Üst sınır: Well-tolerated up to 3,000 mg/day

Araştırmalarda İncelenen Dozajlar

Dozaj	Süre	Etki	N
None	--	Positive	--
None	--	Positive	--
None	--	Mixed	--
None	--	Mixed	--
mitochondrial cofactors + antioxidants	--	Positive	--
None	--	Positive	106
None	--	Positive	427
None	8.0 weeks	Positive	--

En iyi alım zamanı: Morning, on empty stomach or with meals

Safety & Side Effects

Bildirilen Yan Etkiler

⚠ Gastrointestinal discomfort (nausea, vomiting, diarrhea)
⚠ Fishy body odor
⚠ Restlessness or insomnia
⚠ Increased appetite

Bilinen Etkileşimler

● Anticoagulants (may increase bleeding risk)
● Thyroid medications (may enhance thyroid hormone effects)
● AZT (antiretroviral — may reduce neuropathy)

Tolere edilebilir üst alım: Well-tolerated up to 3,000 mg/day

Herhangi bir takviye kullanmaya başlamadan önce mutlaka sağlık uzmanınıza danışın.Herhangi bir takviye başlatmadan önce her zaman sağlık uzmanınıza danışın.

Frequently Asked Questions

Does Acetyl-L-Carnitine help with Age-Related Cognitive Decline?

Based on 14 studies with 1,000 participants, there is limited but promising evidence that Acetyl-L-Carnitine may support Age-Related Cognitive Decline management. Our evidence grade is C (Some Evidence).

How much Acetyl-L-Carnitine should I take for Age-Related Cognitive Decline?

Studies have used various dosages. A commonly studied range is 500-2,000 mg/day. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of Acetyl-L-Carnitine?

Reported side effects may include Gastrointestinal discomfort (nausea, vomiting, diarrhea), Fishy body odor, Restlessness or insomnia, Increased appetite. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for Acetyl-L-Carnitine and Age-Related Cognitive Decline?

We rate the evidence as Grade C (Some Evidence). This rating is based on 14 peer-reviewed studies with 1,000 total participants. The overall direction of effect is positive.

Related Evidence

Şu durum için diğer içerikler: Age-Related Cognitive Decline

Omega-3 Fatty Acids (DHA/EPA) A Phosphatidylserine B Bacopa monnieri B Vitamin B12 B Curcumin B Ginkgo biloba C

Acetyl-L-Carnitine diğer sağlık durumları için

Oxidative Stress & Neuroinflammation C

Hızlı Değerlendirme

Evidence Strength52%

Moderate confidence

Çalışma Dağılımı

RCT (4)Meta (1)Other (9)

Alternatifleri Karşılaştır

Bu durum için diğer bileşenlerin nasıl karşılaştırıldığını görün.Diğer içeriklerin bu sağlık durumu için nasıl karşılaştırıldığını görün.

Şu durum için tüm içerikleri görüntüle: Age-Related Cognitive Decline

Daha Fazla Bilgi

FDA Sorumluluk Reddi: Bu ifadeler Gıda ve İlaç Dairesi (FDA) tarafından değerlendirilmemiştir. Bu web sitesindeki ürünler ve bilgiler herhangi bir hastalığı teşhis etmek, tedavi etmek, iyileştirmek veya önlemek amacıyla tasarlanmamıştır. Sunulan kanıt dereceleri, yayımlanmış hakemli araştırmalarımızın analizine dayanmaktadır ve tıbbi tavsiye niteliği taşımamaktadır. Herhangi bir takviye rejimine başlamadan önce her zaman sağlık uzmanınıza danışın.